A panel discussion with Catalent and industry experts
30 March 2012 | By Catalent Pharma Solutions
Cornell Stamoran, Catalent Pharma Solutions will be a guest panelist at New Jersey’s PharmFest 2012...
List view / Grid view
News
New pharmaceutical filling area for the facility in Pfreimd
30 March 2012 | By Gerresheimer AG
Gerresheimer Medical Plastic Systems continues to expand its range of services in order to meet customer demand...
Roche’s trastuzumab emtansine (T-DM1) showed positive Phase III results in HER2-positive metastatic breast cancer
30 March 2012 | By Roche
Roche have announced topline results of EMILIA...
Abbott’s PLEX-ID Molecular system and tests for broad microbial identification obtain CE Marking
30 March 2012 | By Abbott
New PLEX-ID system and three clinical tests introduced in the European Union...
New incentive plans in the Lundbeck Group
29 March 2012 | By H. Lundbeck A/S
The Board of Directors of H. Lundbeck A/S has resolved, pursuant to the authorisation in article 4.4 of the company's articles...
The University of Nottingham and I Holland collaborate in Anti-Stick Research
29 March 2012 | By I Holland Ltd
I Holland are delighted to announce the launch of a two year TSAR project...
BASF aligns research even more closely to future topics, global markets and customer industries
29 March 2012 | By BASF
BASF is setting itself ambitious goals...
Roche raises offer for Illumina to over $6bn
29 March 2012 | By Roche
Roche increases offer price for gene sequencing firm Illumina to US$ 51.00 per share...
Lundbeck awarded for ethical leadership in the pharmaceutical industry
29 March 2012 | By H. Lundbeck A/S
Lundbeck is becoming the first recipient of a new award for ethical leadership in the pharmaceutical industry...
Gerresheimer at the PDA Parenteral Packaging Conference in Phoenix Arizona
28 March 2012 | By Gerresheimer AG
Gerresheimer will display its comprehensive range of tubular glass...
Agreement to develop diagnostic assays for Alzheimer’s disease
28 March 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Meso Scale Discovery have entered an agreement...
Merck provides update on IMPROVE-IT Trial
28 March 2012 | By Merck
The DSMB of the IMPROVE-IT trial has completed the second pre-specified interim efficacy analysis of the study...
Merck appoints Michael J. Holston as Chief Ethics and Compliance Officer
28 March 2012 | By Merck
Long-time Merck and Schering-Plough Executive Richard S. Bowles to retire...
Novartis launches the CCLE to catalogue world’s cancer cell lines
28 March 2012 | By Novartis
Collaboration with the Broad Institute yields comprehensive encyclopedia of genetic and molecular information...
Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand
27 March 2012 | By Andrew Lloyd & Associates
Novasep announces the opening of a new 2,000 m2 facility in Shanghai Pudong district...
